Romeu B - Search Results

1

2nd international workshop on Neisseria vaccines (Neisseria vaccines 2009).

Romeu B, González E, Campa C, Holst J, Pérez O. Romeu B, et al. Expert Rev Vaccines. 2009 Aug;8(8):987-92. doi: 10.1586/erv.09.71. Expert Rev Vaccines. 2009. PMID: 19627182

2

Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.

Campo JD, Zayas C, Romeu B, Acevedo R, González E, Bracho G, Cuello M, Cabrera O, Balboa J, Lastre M. Campo JD, et al. Among authors: romeu b. Methods. 2009 Dec;49(4):301-8. doi: 10.1016/j.ymeth.2009.03.025. Epub 2009 May 4. Methods. 2009. PMID: 19410000

3

Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1.

Romeu B, González E, Del Campo J, Acevedo R, Zayas C, Valdés Y, Cabrera O, Cuello M, Balboa J, Lastre M, Pérez O. Romeu B, et al. Can J Microbiol. 2011 Mar;57(3):256-61. doi: 10.1139/W11-002. Can J Microbiol. 2011. PMID: 21358768

4

AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses.

Romeu B, González E, Zayas C, Del Campo J, Acevedo R, Cuello M, Valdes Y, Balboa J, Cabrera O, Lastre M, Pérez O. Romeu B, et al. Scand J Infect Dis. 2011 Oct;43(10):809-13. doi: 10.3109/00365548.2011.586648. Epub 2011 Jun 15. Scand J Infect Dis. 2011. PMID: 21671827

5

The golden era of vaccine adjuvants.

Cabrera O, Cuello M, Lastre M, Romeu B, Balboa J, Zayas C, Pérez O. Cabrera O, et al. Among authors: romeu b. Expert Rev Vaccines. 2011 Jul;10(7):1007-9. doi: 10.1586/erv.11.62. Expert Rev Vaccines. 2011. PMID: 21806395

6

Can mucosal adjuvants contribute to the induction of immunological memory induced via unconjugated T-cell-independent antigens?

Romeu B, Gonzalez E, Lastre M, Pérez O. Romeu B, et al. J Drug Target. 2012 Jul;20(6):502-8. doi: 10.3109/1061186X.2012.693497. Epub 2012 May 27. J Drug Target. 2012. PMID: 22632258 Review.

7

Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B.

Zayas C, González D, Acevedo R, del Campo J, Lastre M, González E, Romeu B, Cuello M, Balboa J, Cabrera O, Guilherme L, Pérez O. Zayas C, et al. Among authors: romeu b. BMC Immunol. 2013;14 Suppl 1(Suppl 1):S4. doi: 10.1186/1471-2172-14-S1-S4. Epub 2013 Feb 25. BMC Immunol. 2013. PMID: 23458578 Free PMC article.

8

Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A.

Romeu B, Lastre M, García L, Cedré B, Mandariote A, Fariñas M, Oliva R, Rosenqvist E, Pérez O. Romeu B, et al. Immunol Res. 2014 Jan;58(1):75-85. doi: 10.1007/s12026-013-8427-6. Immunol Res. 2014. PMID: 23660844

9

Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform.

Pérez O, Romeu B, Cabrera O, González E, Batista-Duharte A, Labrada A, Pérez R, Reyes LM, Ramírez W, Sifontes S, Fernández N, Lastre M. Pérez O, et al. Among authors: romeu b. Front Immunol. 2013 Dec 2;4:407. doi: 10.3389/fimmu.2013.00407. Front Immunol. 2013. PMID: 24348475 Free PMC article. Review.

10

Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses.

Romeu B, Lastre M, Reyes L, González E, Borrero Y, Lescaille D, Pérez R, Nuñez D, Pérez O. Romeu B, et al. Vaccine. 2014 Dec 5;32(51):6971-6978. doi: 10.1016/j.vaccine.2014.10.037. Epub 2014 Oct 30. Vaccine. 2014. PMID: 25454865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results